As a follow-up to an earlier post (linked below), this more recent research confirms the heterogeneous and dispersed nature of prostate tissue as cancer develops and may explain the reasons why PCa, especially in an advanced and/or metastatic case, is so difficult to treat.
This excerpt from the MedPage Today article summarizes the issue and the suggestion for using a more complete treatment strategy when surgical removal of the entire prostate is not employed:
A new study published today reveals that the prostate as a whole, including cells that appear normal, is different in men with prostate cancer.
It suggests that tissue cells throughout the whole prostate are primed and ready to develop prostate cancer.
This means that it may be better to treat the whole prostate rather than only the areas in the prostate that have cancer.
The wide-ranging diversity of cellular typology may well explain the similar range of treatment responses seen in advanced PCa. Seems we may need numerous silver bullets to cure PCa for all patients.
The MedPage Today article can be found here:
How prostate cancer may begin, ScienceDaily, September 21, 2022, University of East Anglia.
sciencedaily.com/releases/2...
And the full research paper here:
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates, Molecular Cancer, Published 22 September 2022.
molecular-cancer.biomedcent...
Also, here is a link to the previous post with similar research focus:
healthunlocked.com/fight-pr...
Stay Safe & Well,
Ciao - K9